Alkem Reports 17 Percentage Revenue and 22 Percentage EBITDA Growth in Q2 FY26
Mumbai, November 13, 2025: Alkem Laboratories Ltd., announced its standalone and consolidated financial results for the second quarter ended September 30, 2025. The Board of Directors took record of these results at its meeting held in Mumbai today. Key Financial Metrics Commenting on the Q2 FY26 results, Dr. Vikas Gupta, CEO of Alkem, said, “ […]
Alkem Reports 17 Percentage Revenue and 22 Percentage EBITDA Growth in Q2 FY26 Read More »